INS and gestational diabetes: It is striking that our “real world” data identified variables predictive of subsequent insulin requirement similar to those identified in a recent systematic review of personalised medicine approaches in gestational diabetes approaches [21]; we support the suggestion of these authors that future research should harness more complex “omic” technology to further advance the application of personalised medicine within GDM management.